Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis

Ann Rheum Dis. 2020 Aug 25;annrheumdis-2020-218690. doi: 10.1136/annrheumdis-2020-218690. Online ahead of print.
No abstract available

Keywords: cytokines; dermatomyositis; therapeutics.

Publication types

  • Letter